Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

Phase 0 lead-in trial of Pitavastatin in primary and recurrent Glioblastoma patients

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Other

Sponsor

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Enrolment target

18

Start

16 Oct 2023

Glioblastoma Multiforme

Who may be eligible?

Age 18 Years to any · Sex: All

Locations (1)

—
Netherlands

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.